Hutch News
Results per Page:
Dedicated supporters at the Heart of the Hutch
Using creativity and passion to support Fred Hutch research in good times and bad
Six researchers receive $3.5 million in grants from Kuni Foundation
Funds will support innovative high-risk/high-reward projects across Fred Hutchinson Cancer Center/University of Washington/Seattle Children’s Cancer Consortium with the potential to revolutionize care
Meet Global Oncology's deputy program head
Key early experiences shaped Dr. Thomas Uldrick's path toward HIV-associated cancers, global health
Burkitt's Lymphoma Fund for Africa partners with Fred Hutch to carry on its founder's passion
Partnering with Fred Hutch Global Oncology, Burkitt’s Lymphoma Fund for Africa carries on its founder’s passion
Fertility after cancer: Young women less likely to be told about options
New study finds young male cancer patients twice as likely to be counseled on preserving fertility
Eye on a cure: Bandage contact lenses may heal ocular graft-vs.-host disease
Small study shows big benefit from contacts that soothe debilitating side effects
Can’t quit: Nearly 10 percent of cancer patients still smoke
Nearly nine years after diagnosis, bad habits die hard, and some say ‘What’s the point?'
Cancerversaries: Survivors mark milestones with tattoos, feats of strength, fundraising
Tattoos, feats of strength and fundraising are some of the ways patients observe significant dates
New drug shows promise in treating slow-growing non-Hodgkin lymphomas
Idelalisib could be on the market later this year, pending FDA approval
New drug shows promise in treating indolent non-Hodgkin lymphomas - Fred Hutchinson Cancer Research Center
Idelalisib could be on the market later this year, pending FDA approval
Fang wins three-year LLS fellowship grant
Chen Fang's $165,000 Leukemia & Lymphoma Society Fellow Award will support design of pretargeted nanotherapeutics for fighting non-Hodgkin lymphoma
Fang wins three-year LLS fellowship grant
Fred Hutchinson Cancer Research Center's Chen Fang will use $165,000 Leukemia & Lymphoma Society Fellow Award to support design of pretargeted nanotherapeutics for fighting non-Hodgkin lymphoma
Rezvani wins American Cancer Society grant
The $583,000 four-year research award will aid research using monoclonal antibodies to lower the chances of non-Hodgkin lymphoma relapse, complications
Budde granted Leukemia & Lymphoma Society funding
$195,000 career development award propels T-cell lymphoma research